Literature DB >> 9305516

Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.

L J Thal1, A Carta, R Doody, P Leber, R Mohs, L Schneider, S Shimohama, C Silber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9305516

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN： 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  7 in total

Review 1.  The prediction and prevention of Alzheimer's disease--towards a research agenda.

Authors:  R van Reekum; M Simard; T Cohen
Journal:  J Psychiatry Neurosci       Date:  1999-11       Impact factor: 6.186

2.  Evolving early (pre-dementia) Alzheimer's disease trials: suit the outcomes to the population and study design.

Authors:  R S Doody
Journal:  J Nutr Health Aging       Date:  2010-04       Impact factor: 4.075

Review 3.  Galantamine: a review of its use in Alzheimer's disease.

Authors:  L J Scott; K L Goa
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

Review 4.  Recruitment methods for United States Alzheimer disease prevention trials.

Authors:  L S Schneider
Journal:  J Nutr Health Aging       Date:  2012-04       Impact factor: 4.075

Review 5.  Rivastigmine. A review of its use in Alzheimer's disease.

Authors:  C M Spencer; S Noble
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

Review 6.  Prevention of Alzheimer disease. Encouraging evidence.

Authors:  Monica Zavaloni Scalco; Robert van Reekum
Journal:  Can Fam Physician       Date:  2006-02       Impact factor: 3.275

7.  A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease.

Authors:  L S Schneider
Journal:  Dialogues Clin Neurosci       Date:  2000-06       Impact factor: 5.986
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.